Euroscreen awarded US patent on GPC receptor
21/09/2005 - Euroscreen has announced the issuance of a US patent, which covers the use of a human G-protein-coupled receptor (GPCR) human P2Y13. The patent protects screening processes using this receptor to find compounds that modulate its activity, thus having pharmaceutical potential.
